Dana Point, CA, United States of America

John E Donello

Average Co-Inventor Count = 4.4

ph-index = 9

Forward Citations = 480(Granted Patents)

Forward Citations (Not Self Cited) = 284(Sep 21, 2024)

DiyaCoin DiyaCoin 0.51 

Inventors with similar research interests:


Location History:

  • San Clemente, CA (US) (2016)
  • Dana Point, CA (US) (2001 - 2022)


Years Active: 2001-2022

where 'Filed Patents' based on already Granted Patents

136 patents (USPTO):
23 patents (CIPO):

Title: John E Donello: Pioneering Innovator in Pharmaceutical Compositions

Introduction:

In the world of pharmaceutical research and development, certain individuals leave an indelible mark with their innovative contributions. John E Donello is one such visionary inventor who has made significant breakthroughs in the field. Based in Dana Point, CA, John E Donello has amassed an impressive number of patents and has worked with renowned companies such as Allergan, Inc. and Exonhit Therapeutics, SA. This article delves into his latest patents, career highlights, notable collaborations, and the lasting impact of his work.

Latest Patents:

One of John E Donello's recent patents encompasses his groundbreaking invention: pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole derivatives for treating retinal diseases. These compositions serve as potential pharmaceuticals for the treatment of retinal diseases, retinal neuroprotection, and vision enhancement. This innovative approach demonstrates Donello's dedication to addressing medical challenges and improving patients' lives.

Additionally, he holds a patent related to the use of 3,4-disubstituted 3-cyclobutene-1,2-diones in treating inflammatory and autoimmune diseases. These compounds open avenues for developing novel therapies for patients with these conditions.

Career Highlights:

With an impressive total of 136 patents to his name, John E Donello has achieved notable recognition within the pharmaceutical industry. Throughout his career, he has displayed a keen ability to identify unmet medical needs and devise novel solutions to address them. His patents demonstrate a diverse range of innovative ideas and approaches that have the potential to vastly impact patient care in various therapeutic areas.

Collaborations:

Collaboration plays a crucial role in fostering innovation, and John E Donello has had the pleasure of working with accomplished professionals in his field. Noteworthy collaborators include Michael E Garst and Richard L Beard. Their combined expertise and collaborative efforts have undoubtedly contributed to the success of several groundbreaking inventions.

Conclusion:

John E Donello's innovative contributions and remarkable patent portfolio cement his status as a pioneering inventor in the pharmaceutical industry. His dedication to finding solutions for retinal diseases and his exploration of potential treatments for inflammatory and autoimmune conditions highlight his commitment to improving patient outcomes. With an impressive career spanning across prominent companies, John E Donello's work serves as a testament to the power of innovation and collaboration in advancing medical research and patient care.

For further information about John E Donello's patents, career, and other notable inventors and inventions, be sure to visit our website idiyas.com, where you can explore a wealth of information about the world of innovations and patents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…